Tagata, Letecia M.
HRN: 21-37-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/09/2023
07/15/2023
IVT
1.5gms
Q6
T/c Hap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes